We identified a human-specific lncRNA, BAZ1A-AS1 , and its predicted cis-regulatory gene, BAZ1A , as key molecular regulators of neointima formation in human SV. These findings highlight the BAZ1A-AS1/BAZ1A axis as a potential therapeutic target for preventing SV graft failure following CABG.
Kim et al. (Thu,) studied this question.